Catalyst Pharmaceuticals
CPRX
#3987
Rank
ยฃ2.17 B
Marketcap
ยฃ17.66
Share price
1.95%
Change (1 day)
3.86%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ98.6 Million

According to Catalyst Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ98.6 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalyst Pharmaceuticals - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ98.63 M52.81%
2023-12-31ยฃ64.54 M3.83%
2022-12-31ยฃ62.16 M171.07%
2021-12-31ยฃ22.93 M37.37%
2020-12-31ยฃ16.69 M-11.53%
2019-12-31ยฃ18.87 M147.82%
2018-12-31ยฃ7.61 M132.65%
2017-12-31ยฃ3.27 M68.42%
2016-12-31ยฃ1.94 M-37.74%
2015-12-31ยฃ3.12 M-43.93%
2014-12-31ยฃ5.56 M130.78%
2013-12-31ยฃ2.41 M79.88%
2012-12-31ยฃ1.34 M-16.26%
2011-12-31ยฃ1.6 M687.87%
2010-12-31ยฃ0.2 M-5.65%
2009-12-31ยฃ0.21 M-78.57%
2008-12-31ยฃ1 M458.93%
2007-12-31ยฃ0.17 M-54.43%
2006-12-31ยฃ0.39 M98.37%
2005-12-31ยฃ0.19 M463.19%
2004-12-31ยฃ0.03 M
2002-12-31ยฃ0.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioMarin Pharmaceutical
BMRN
ยฃ1.16 B 1,086.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.63 B 1,554.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.22 B 86,335.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ0.20 B 103.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 87,931.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ24.70 B 24,959.19%๐Ÿ‡บ๐Ÿ‡ธ USA